Article Details
Retrieved on: 2025-01-20 13:08:22
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Boston Scientific's successful trial of its MedTech device, the pulsed field ablation system, for treating paroxysmal atrial fibrillation. The study highlights advancements in cardiac electrophysiology, showing promise for arrhythmia management.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here